EUVIMEDEUVIMED entdecken
Crossref

Broad Mucosal and Systemic Immunity in Mice Induced by Intranasal Booster With a Novel Recombinant Adenoviral Based Vaccine Protects Against Divergent Influenza A Virus

Jia Li, Tangqi Wang, Xiaojuan Guo, Yujie Jiang, Liye Jin, Qiaohong Chu, Xuchang Shan, Lingfang Zhang, Ruiwen Han, Chengcheng Zhai, Donghong Wang, Yao Deng und 3 weitere

Journal of Medical Virology · 2025-04 · 97 (4)

DOI: 10.1002/jmv.70326 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Medical Virology, online erschienen am 27.03.2025. Verfasst von Jia Li und 14 weiteren Autor:innen. Beteiligte Einrichtung: Zhejiang Provincial Key Laboratory of Medical Genetics, School of Laboratory Medicine and Life Sciences, Wenzhou Medical University, Wenzhou, China. Hauptthemen laut MEDLINE: Influenza Vaccines, Orthomyxoviridae Infections, Immunity, Mucosal, Immunization, Secondary. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 66 Literaturangaben. Gefördert von: This study was supported by grants from the National Key Research and Development Program of China [grant number 2022YFC2304100] and the National Natural Scien….

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The development of broad‐spectrum universal influenza vaccines and optimization of vaccination strategies to address the threats posed by pandemics and emerging influenza viruses are critical for public health. In this study, an adenovirus type 5 vector‐based influenza vaccine carrying the hemagglutinin (HA) stem of H1, HA stem of H3, and neuraminidase (NA) of N1 from the influenza virus was constructed. Immune responses were evaluated in mice using various vaccination strategies: prime‐only (intramuscular [IM] or intranasal [IN]) and prime‐boost (IM + IN). Compared with the prime‐only strategy, the prime‐boost strategy significantly enhanced the systemic immune response, inducing higher levels of antigen‐specific IgG, mucosal IgA, and T cell immunity in the spleen and lungs. Furthermore, the IN boosting strategy provided complete protection in mice challenged with the H1N1‐PR8, rgH3N2‐X31, and rgH5N1‐Vietnam viruses, significantly reducing viral loads in the lungs and alleviating lung tissue pathologies. In conclusion, this study elucidates potential avenues for the development and application of universal influenza vaccines using customized mucosal boosting strategies.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Influenza VaccinesOrthomyxoviridae InfectionsImmunity, MucosalImmunization, SecondaryInfluenza A virusAnimalsAdministration, IntranasalAntibodies, ViralMiceAdenoviridaeLungVaccines, SyntheticMice, Inbred BALB CFemaleImmunoglobulin AImmunoglobulin GHemagglutinin Glycoproteins, Influenza VirusGenetic VectorsViral LoadSpleenT-Lymphocytes

Stichwörter der Autor:innen

adenovirus vector‐based influenza vaccineintranasal boostermucosal immunitysystemic immunityuniversal influenza vaccine

Substanzen

Influenza VaccinesAntibodies, ViralVaccines, SyntheticImmunoglobulin AImmunoglobulin GHemagglutinin Glycoproteins, Influenza Virus

Autor:innen und Institutionen

  • Zhejiang Provincial Key Laboratory of Medical Genetics, School of Laboratory Medicine and Life Sciences, Wenzhou Medical University, Wenzhou, China.
  • National Key Laboratory of Intelligent Tracking and Forecasting for Infectious Diseases, Key Laboratory of Biosafety, National Health Commissions, National Institute for Viral Disease Control and Prevention, China CDC,…
  • School of Public Health, Xinxiang Medical University, Xinxiang, China.
  • School of Basic Medical Sciences, Inner Mongolia Medical University, Hohhot, China.

Förderung

  • This study was supported by grants from the National Key Research and Development Program of China [grant number 2022YFC2304100] and the National Natural Scien…

Zitieren

APA

Li, J., Wang, T., Guo, X., Jiang, Y., Jin, L., Chu, Q., Shan, X., Zhang, L., Han, R., Zhai, C., Wang, D., Deng, Y., Huang, B., Lu, Z., & Tan, W. (2025). Broad Mucosal and Systemic Immunity in Mice Induced by Intranasal Booster With a Novel Recombinant Adenoviral Based Vaccine Protects Against Divergent Influenza A Virus. Journal of Medical Virology, 97(4). https://doi.org/10.1002/jmv.70326

Vancouver

Li J, Wang T, Guo X, Jiang Y, Jin L, Chu Q, et al. Broad Mucosal and Systemic Immunity in Mice Induced by Intranasal Booster With a Novel Recombinant Adenoviral Based Vaccine Protects Against Divergent Influenza A Virus. Journal of Medical Virology. 2025;97(4). doi:10.1002/jmv.70326

BibTeX
@article{Li2025,
  author = {Li, Jia and Wang, Tangqi and Guo, Xiaojuan and Jiang, Yujie and Jin, Liye and Chu, Qiaohong and Shan, Xuchang and Zhang, Lingfang and Han, Ruiwen and Zhai, Chengcheng and Wang, Donghong and Deng, Yao and Huang, Baoying and Lu, Zhuozhuang and Tan, Wenjie},
  title = {Broad Mucosal and Systemic Immunity in Mice Induced by Intranasal Booster With a Novel Recombinant Adenoviral Based Vaccine Protects Against Divergent Influenza A Virus},
  journal = {Journal of Medical Virology},
  year = {2025},
  volume = {97},
  number = {4},
  doi = {10.1002/jmv.70326}
}
Kostenlos starten →